Jose Serrano

Dr. Jose Serrano

Department of Experimental Medicine, University of Lleida, Lleida, Spain
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2009 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
Jose SerranoJose Serrano
Jose Serrano
RPRiitta Puupponen-Pimiä
Riitta Puupponen-Pimiä
ADAndreas Dauer
Andreas Dauer
AAAnna‐Marja Aura
Anna‐Marja Aura
FSFulgencio Saura‐Calixto
Fulgencio Saura‐Calixto

1 January 2007 in Food Chemistry
Verified
Journal Article
Closed access
FSFulgencio Saura-Calixto
Fulgencio Saura-Calixto
Jose SerranoJose Serrano
Jose Serrano
IGIsabel Goñi
Isabel Goñi

1 January 2008 in Food Research International
Verified
Journal Article
Closed access
JPJara Pérez-Jiménez
Jara Pérez-Jiménez
SASara Arranz
Sara Arranz
MTMaria Tabernero
Maria Tabernero
MRM. Elena Díaz- Rubio
M. Elena Díaz- Rubio
Jose SerranoJose Serrano
Jose Serrano
FSFulgencio Saura-Calixto
Fulgencio Saura-Calixto

13 September 2010 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre
NANathalie Auge
Nathalie Auge
VAVictoria Ayala
Victoria Ayala
HBHuveyda Basaga
Huveyda Basaga
JBJordi Boada
Jordi Boada
Neven ZarkovicNeven Zarkovic
Neven Zarkovic
Lipid peroxidation (LPO) product accumulation in human tissues is a major cause of tissular and cellular dysfunction that plays a major role in ageing and most age-related and oxidative stress-related diseases. The current evidence for the implication of LPO in pathological processes is discussed in this review. New data and literature review are provided evaluating the role of LPO in the pathophysiology of ageing and classically oxidative stress-linked diseases, such as neurodegenerative diseases, diabetes and atherosclerosis (the main cause of cardiovascular complications). Striking evidences implicating LPO in foetal vascular dysfunction occurring in pre-eclampsia, in renal and liver diseases, as well as their role as cause and consequence to cancer development are addressed.

1 July 2008 in Nutrition
Verified
Journal Article
Closed access
JPJara Pérez-Jiménez
Jara Pérez-Jiménez
Jose SerranoJose Serrano
Jose Serrano
MTMaria Tabernero
Maria Tabernero
SASara Arranz
Sara Arranz
MDM. Elena Díaz-Rubio
M. Elena Díaz-Rubio
FSFulgencio Saura-Calixto
Fulgencio Saura-Calixto

11 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AGA. B. Granado-Serrano
A. B. Granado-Serrano
MMMeritxell Martin
Meritxell Martin
VSV. Sánchez
V. Sánchez
MSM. Riart Solans
M. Riart Solans
RBR. Berdún
R. Berdún
Jose SerranoJose Serrano
Jose Serrano
Gut microbiota has been suggested to affect lipid metabolism. The objective of this study was to characterize the faecal microbiota signature and both short chain fatty acids (SCFAs) and bile acids (BA) profile of hypercholesterolemic subjects. Microbiota composition, SCFAs, BA and blood lipid profile from male volunteers with hypercholesterolemia (HC) and normocholesterolemia (NC) were determined by 16S rDNA sequencing, HPLC, GC and NMR, respectively. HC subjects were characterized by having lower relative abundance of Anaeroplasma (0.002% vs 0.219%, p-value = 0.026) and Haemophilus (0.041% vs 0.078%, p-value = 0.049), and higher of Odoribacter (0.51% vs 0.16%; p-value = 0.044). Correlation analysis revealed that Anaeroplasma and Haemophilus were associated to an unfavourable lipid profile: they correlated negatively to cholesterol and triglycerides related biomarkers and the ratio total to high density lipoprotein (HDL) cholesterol, and positively to HDL size. Odoribacter displayed an opposite behaviour. Faecal SCFAs profile revealed higher abundance of isobutyric (2.76% vs 0.82%, p-value = 0.049) and isovaleric acid (1.32% vs 0.06%, p-value = 0.016) in HC. Isobutyric acid correlated positively with Odoribacter and lipid parameters indicative of an unfavourable profile. BA profile did not show differences between groups. It was concluded that HC subjects showed a particular faecal bacterial signature and SCFAs profile associated with their lipid profile.